About Asthma, Nasal Disease, and Allergy Research Center of New England
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Genentech, Inc.
3
Meda Pharmaceuticals
3
Regeneron Pharmaceuticals
3
Sunovion
3
Aerovance, Inc.
1
Celldex Therapeutics
1
Clinical Trials at Asthma, Nasal Disease, and Allergy Research Center of New England
During the past decade, Asthma, Nasal Disease, and Allergy Research Center of New England conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 3 clinical trials were completed, i.e. on
average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Perennial Allergies
2007-01-01
Completed
581
A Study to Evaluate the Safety & Effectiveness of a Nasal Spray to Treat Seasonal Allergies
2007-08-01
2007-11-01
Completed
481
A Study to Evaluate the Safety and Tolerability of a Nasal Spray to Treat Perennial Allergic Rhinitis
2007-03-01
2008-07-01
Completed
703
A Study of the Treatment-Sparing Effects of AEROVANT™ AER 001 Inhalation Powder in Asthma Patients, AEROTRIAL
2009-03-01
2010-02-01
Completed
424
A 6 Month Safety and Efficacy Study of Once Daily Ciclesonide Hydrofluoroalkane (HFA) in the Treatment of Perennial Allergic Rhinitis (PAR) in Subjects 12 Years and Older
2009-08-01
2010-05-01
Completed
1,110
A 6 Month Study of Once Daily Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol in The Treatment of Perennial Allergic Rhinitis (PAR) in Subjects 12 Years and Older
2010-02-01
2010-11-01
Completed
824
A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Seasonal Allergic Rhinitis (SAR)
2011-11-01
2013-03-01
Completed
847
A Study of the Efficacy and Safety of Omalizumab Through 48 Weeks in Participants With Chronic Idiopathic Urticaria
2015-05-18
2017-03-09
Completed
206
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Asthma, Nasal Disease, and Allergy Research Center of New England" #1 sponsor was "Genentech, Inc." with 3 trials, followed by "Meda Pharmaceuticals" with 3 trials
sponsored, "Regeneron Pharmaceuticals" with 3 trials sponsored, "Sunovion" with 3 trials sponsored and "Aerovance, Inc."
with 3 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Asthma, Nasal Disease, and Allergy Research Center of New England"
#1 collaborator was "Sanofi" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Asthma, Nasal Disease, and Allergy Research Center of New England
According to Clinical.Site data, the most researched conditions in "Asthma, Nasal Disease, and Allergy Research Center of New England" are
"Perennial Allergic Rhinitis" (4 trials), "Urticaria" (3 trials), "Asthma" (2 trials), "Seasonal Allergic Rhinitis" (2 trials) and "Allergic Rhinitis" (1 trials). Many other conditions were trialed in "Asthma, Nasal Disease, and Allergy Research Center of New England" in a lesser frequency.
Clinical Trials Intervention Types at Asthma, Nasal Disease, and Allergy Research Center of New England
Most popular intervention types in "Asthma, Nasal Disease, and Allergy Research Center of New England" are "Drug" (14 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "0.15% azelastine hydrochloride" (2 trials), "DUPIXENT®" (2 trials), "GDC-0853" (2 trials) and "0.1% azelastine hydrochloride" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Asthma, Nasal Disease, and Allergy Research Center of New England
The vast majority of trials in "Asthma, Nasal Disease, and Allergy Research Center of New England" are
13 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Asthma, Nasal Disease, and Allergy Research Center of New England
Currently, there are NaN active trials in "Asthma, Nasal Disease, and Allergy Research Center of New England".
undefined are not yet recruiting,
2 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 10 completed trials in Asthma, Nasal Disease, and Allergy Research Center of New England,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Asthma, Nasal Disease, and Allergy Research Center of New England, 1 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 7 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".